Iriva Medical
- Headquarters
- Minneapolis
- Business Model
- B2B
- Website
- irivamedical.com
- Last Round
- SeedNov 2025
- Rounds
- 1
About
iRiva Medical, Inc. is a development-stage medical device company based in Minneapolis, Minnesota, developing next-generation neuromodulation technology platforms aimed at treating chronic pain and neurological conditions that affect large patient populations. The company is the fourth spinoff from medical device accelerator NuXcel and is backed by a venture syndicate including F-Prime Capital and Treo Ventures. iRiva Medical announced the close of its initial financing round in November 2025 to advance its neuromodulation therapies toward unmet clinical needs.
Summary
Iriva Medical is a Biotech company based in Minneapolis, United States. Its most recent funding was a Seed round in Nov 2025. Investors include F-Prime Capital, Hatteras Venture Partners and Shiv Chaudhary.
Tech & App Stack
3 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Nov 2025
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company